IDEX Raises Quarterly Dividend 2.8% to $0.73

IDEX Corporation raised its quarterly dividend to $0.73 a share from $0.71, an increase of 2.8%. Shares traded ex-dividend on May 22, 2026, and the next ex-dividend date is October 2, 2026. The new rate equates to an annual dividend of $2.92 a share.

Why the dividend changed

IDEX’s declaration said the board approved a regular quarterly cash dividend but gave no event-specific explanation for the increase. The payment was not presented as part of a split, merger, spin-off or special distribution. It continues the company’s established practice of returning cash while funding organic investment, acquisitions and share repurchases.

The operating backdrop had strengthened before the decision. IDEX reported first-quarter sales of $887 million, up 9% as reported and 5% organically, while adjusted diluted earnings per share rose 14% to $2.00. Orders reached a record $988 million, increasing 13% as reported. The company raised its full-year organic sales growth guidance to 3% to 4% and its adjusted diluted earnings guidance to $8.35 to $8.55, according to its first-quarter results.

Management attributed the first-quarter momentum primarily to Health & Science Technologies, where demand from data-center power, semiconductor, space and defense markets outweighed weakness in life sciences. IDEX’s capital-allocation presentation describes reliable, consistent dividends as one part of a balanced framework that also funds acquisitions and repurchases.

The latest update strengthened that context after the increase. Second-quarter results showed record sales of $921 million, up 6% as reported and 5% organically, and record adjusted diluted earnings per share of $2.32, up 12%. Orders exceeded $1 billion and IDEX raised its full-year organic growth and adjusted earnings guidance again.

Dividend track record

The increase extends IDEX’s dividend-growth streak to 30 consecutive years. The annual total rose from $2.00 in 2020 to $2.12 in 2021, $2.34 in 2022, $2.52 in 2023, $2.71 in 2024 and $2.82 in 2025. Every full year in that sequence recorded an increase, although the pace moderated from 10.4% in 2022 to 4.1% in 2025. The latest 2.8% increase is also below the five-year rate of 7.3% annual growth.

The payment history shows gradual step-ups rather than irregular distributions. The quarterly rate was $0.69 on October 11, 2024, and January 17, 2025. It increased to $0.71 beginning with the May 19, 2025, ex-dividend date and remained there through January 16, 2026. The $0.73 rate applied on May 22, 2026, and July 6, 2026. That pattern is consistent with a measured annual reset to the regular quarterly dividend.

Is the dividend covered?

The dividend consumes 52% of earnings. That leaves a portion of reported earnings for reinvestment, acquisitions, debt management and share repurchases while funding the quarterly distribution. The ratio is material enough that earnings performance remains relevant to future dividend decisions, but it does not indicate that the current payment absorbs nearly all earnings.

SmarterDividends rates the dividend A, with a safety score of 94. That falls in the very safe range of 80-100. In plain terms, the grade indicates strong coverage and a comparatively low risk of a reduction based on the financial measures included in the assessment. It is not a guarantee, particularly for an industrial company exposed to changes in capital spending and end-market demand.

Yield and valuation

At a share price of $230.59, IDEX’s forward yield is 1.27%, below the Industrials sector median of 1.61%. The shares have recorded a 30.5% gain over one year, which helps explain why the yield remains below the sector benchmark despite the higher dividend. At the new rate, 100 shares produce annual dividend income of $292.00.

The SmarterDividends fair-value estimate is $137.05, producing an overvalued verdict and 39% downside relative to fair value. That valuation assessment is separate from dividend safety: the A safety grade addresses the payment’s coverage, while the fair-value estimate compares the share price with an assessment of underlying value.

What to watch

The next identified dividend milestone is the October 2, 2026, ex-dividend date. Investors must track subsequent board declarations for confirmation of the rate and the corresponding payment date.

The next quarterly earnings release will provide updated evidence on order conversion, cash generation and the raised full-year outlook. Health & Science Technologies remains central because data-center power, semiconductor, space and defense demand has driven recent growth. Trends in life sciences, chemical, general industrial and European rescue markets also matter because recent company reports identified softer activity in those areas.

Capital allocation is the other concrete item to monitor. IDEX continues to balance dividends and repurchases with bolt-on acquisitions and organic growth spending. Changes in acquisition activity, leverage or cash conversion would affect the resources available across those competing uses, even though the present earnings payout ratio and safety grade indicate that the regular dividend is covered.